Article Versions Notes

Chandrasekaran B, Bayan MF, Hmedat A, Al-Jaidi BA, Al-Tawalbeh DM, Abuarqoub D, Rasras AJ, Jaradat DMM, Dakkah AN, Hourani W, et al. Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors. Pharmaceuticals. 2025; 18(2):153. https://doi.org/10.3390/ph18020153

Chandrasekaran, Balakumar, Mohammad F. Bayan, Ali Hmedat, Bilal A. Al-Jaidi, Deniz M. Al-Tawalbeh, Duaa Abuarqoub, Anas J. Rasras, Da’san M. M. Jaradat, Abdel Naser Dakkah, Wafa Hourani, and et al. 2025. "Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors" Pharmaceuticals 18, no. 2: 153. https://doi.org/10.3390/ph18020153

Chandrasekaran, B., Bayan, M. F., Hmedat, A., Al-Jaidi, B. A., Al-Tawalbeh, D. M., Abuarqoub, D., Rasras, A. J., Jaradat, D. M. M., Dakkah, A. N., Hourani, W., & Karpoormath, R. (2025). Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors. Pharmaceuticals, 18(2), 153. https://doi.org/10.3390/ph18020153